相关实验视频
Updated: Jun 22, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.4K
进行手术治疗的初级aldosteronism
1OSU Comprehensive Adrenal Program, Division of Surgical Oncology, Department of Surgery.
The Surgical clinics of North America
|June 29, 2024
概括
高血压或高血压会导致严重的健康问题. 这篇综述涵盖了原发性阿尔多斯特隆症 (PA),这是一种导致高血压的内分泌疾病,并讨论了其评估和管理.
科学领域:
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
- 内部医学 内部医学
背景情况:
- 高血压是许多并发病和死亡的重要危险因素.
- 内分泌疾病被认为是导致高血压发展的因素.
- 原发性阿尔多斯特隆症 (PA) 是二次高血压的关键内分泌原因.
研究的目的:
- 为了提供对初级阿尔多斯特主义的评估的全面概述.
- 概述当前用于初级阿尔多斯特主义的管理策略.
- 提高对PA在高血压中的作用的临床理解.
主要方法:
- 综述当前关于原发性阿尔多斯特主义的文献.
- 对PA的诊断指南的综合.
- 对PA的治疗方法的总结.
主要成果:
- 主要的阿尔多斯特主义是高血压的未被确诊的原因.
- 早期诊断和适当的治疗可以改善患者的治疗结果.
- 目前的诊断算法包括生物化学查和确认性测试.
结论:
- 主要的阿尔多斯特主义需要在高血压患者中进行系统的评估.
- 对PA存在有效的管理策略,包括医疗和手术选择.
- 解决PA可以减轻相关的心血管风险并改善死亡率.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
Antihypertensive Drugs: Direct Renin Inhibitors
557
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
557
Antihypertensive Drugs: Potassium-Sparing Diuretics
511
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
511
Adrenal Gland Disorders
1.5K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K
Peptic Ulcer Disease V: Surgical Management and Nursing Care
285
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
285
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
702
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
702

